[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]  Daily Monitor [@DailyMonitor](/creator/twitter/DailyMonitor) on x 2M followers Created: 2025-06-19 17:01:27 UTC The U.S. Food and Drug Administration on Wednesday approved Gilead Sciences GILD.O lenacapavir, a twice-yearly injection, for preventing HIV infection in adults and adolescents. #MonitorUpdates  XXXXXX engagements  **Related Topics** [gilead sciences](/topic/gilead-sciences) [stocks healthcare](/topic/stocks-healthcare) [Post Link](https://x.com/DailyMonitor/status/1935744751514665032)
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Daily Monitor @DailyMonitor on x 2M followers
Created: 2025-06-19 17:01:27 UTC
The U.S. Food and Drug Administration on Wednesday approved Gilead Sciences GILD.O lenacapavir, a twice-yearly injection, for preventing HIV infection in adults and adolescents.
#MonitorUpdates
XXXXXX engagements
Related Topics gilead sciences stocks healthcare
/post/tweet::1935744751514665032